Jet injectors, enemas, oxygen concentrators, intrauterine devices, coal tar, and other methods are examples of Drug Delivery Devices. When administering medication topically or intravenously to humans, drug delivery systems are used. Nebulizers, pressurised metered-dose nebulizer treatments (MDIs), and dry powder inhalers (DPIs) are the three main types of inhaled Medication Delivery Devices. Each category has certain advantages and disadvantages. Aerosol administration is a useful method for administering a medicinal chemical in the treatment of illness. An effective drug delivery device must produce an aerosol of the right size, ideally between 0.5 and 5 m, and provide repeatable drug doses. It should also safeguard the medication formulation's physical and chemical stability. Additionally, the optimum breathing system must be a portable, cost-effective, straightforward device. With the development of liquid nebulizers at the turn of the 19th century, these early remedies evolved into respectable Pharmacological Medicines.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico